In a series of stringent actions being taken against spurious | Index
In a series of stringent actions being taken against spurious medications making substandard drugs following the incidents reports in Gambia and Uzbekistan, official sources from the government have claimed that the Drug Controller General of India (DCGI), the country's drug regulator, has cracked the whip on 76 firms and cancelled product permissions of three firms.
